Authors:
Address: Respiratory Physiology Laboratory, Christchurch Hospital, Christchurch, New Zealand. paul.kelly@cdhb.govt.nz
Journal:

Publication:

abstract

INTRODUCTION:

altitude exposure will cause moderate to severe hypoxemia in patients with chronic obstructive pulmonary disease (COPD). Supplemental oxygen can be used to attenuate this hypoxemia; however, individual response is variable and difficult to predict. The aim of this study was to assess the efficacy of oxygen supplementation in patients with COPD at a barometric pressure similar to that of a commercial aircraft cabin.

METHODS:

Following sea-level (40 m) arterial blood gases measurements, 18 patients with COPD were driven to altitude (2086 m), where blood gases were repeated at rest and while on 2 L x min(-1) of supplementary oxygen (altitude O2).

RESULTS:

Ascent from sea level to altitude caused significant hypoxemia (75 +/- 9 vs. 51 +/- 6 mmHg), which was partially reversed by supplemental oxygen (64 +/- 9 mmHg). Oxygen supplementation did not significantly alter PaCO2 levels (vs. altitude PaCO2). There was a significant relationship between the sea-level CaO2 versus the altitude O2 CaO2 (r = 0.89, P < 0.001). There was a significant relationship (r = 0.81, P < 0.001) between altitude-induced desaturation and resaturation with the administration of oxygen. There was a significant negative correlation (r = -0.74, P < 0.001) between baseline K(CO) and the improvement in CaO2 with the administration of oxygen.

CONCLUSION:

Low-flow supplemental oxygen during acute altitude exposure will partially reverse altitude-induced hypoxemia in patients with COPD. Patients with diffusion impairments are likely to experience the greatest altitude desaturation, but will gain the most benefit from supplemental oxygen. Supplemental oxygen, delivered at 2 L x min(-1), should maintain clinically acceptable oxygenation during commercial air travel in patients with COPD.

Related Articles
Resting and exercise response to altitude in patients with chronic obstructive pulmonary disease.
Aviat Space Environ Med. 2009
Resting and exercise response to altitude in patients with chronic obstructive pulmonary disease.
Kelly PT, Swanney MP, Stanton JD, Frampton C, Peters MJ, Beckert LE. Aviat Space Environ Med. 2009 Feb; 80(2):102-7.
Rehabilitation of hypoxemic patients with COPD at low altitude at the Dead Sea, the lowest place on earth.
Chest. 1998
Rehabilitation of hypoxemic patients with COPD at low altitude at the Dead Sea, the lowest place on earth.
Kramer MR, Springer C, Berkman N, Glazer M, Bublil M, Bar-Yishay E, Godfrey S. Chest. 1998 Mar; 113(3):571-5.
Hemodynamic effects of altitude exposure and oxygen administration in chronic obstructive pulmonary disease.
Am J Med. 1993
Hemodynamic effects of altitude exposure and oxygen administration in chronic obstructive pulmonary disease.
Berg BW, Dillard TA, Derderian SS, Rajagopal KR. Am J Med. 1993 Apr; 94(4):407-12.
Review Do lung disease patients need supplemental oxygen at high altitude?
High Alt Med Biol. 2009
Review Do lung disease patients need supplemental oxygen at high altitude?
Luks AM. High Alt Med Biol. 2009 Winter; 10(4):321-7.
Review Exertional desaturation in patients with chronic obstructive pulmonary disease.
COPD. 2009
Review Exertional desaturation in patients with chronic obstructive pulmonary disease.
Panos RJ, Eschenbacher W. COPD. 2009 Dec; 6(6):478-87.

To top • Home

---

Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer • webmaster